These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16893613)

  • 1. Co-administration of ramelton and fluvoxamine to increase levels of interleukin-2.
    Kast RE; Altschuler EL
    Med Hypotheses; 2006; 67(6):1389-90. PubMed ID: 16893613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
    von Bahr C; Ursing C; Yasui N; Tybring G; Bertilsson L; Röjdmark S
    Eur J Clin Pharmacol; 2000 May; 56(2):123-7. PubMed ID: 10877005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin.
    Härtter S; Wang X; Weigmann H; Friedberg T; Arand M; Oesch F; Hiemke C
    J Clin Psychopharmacol; 2001 Apr; 21(2):167-74. PubMed ID: 11270913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bioavailability of oral melatonin after fluvoxamine coadministration.
    Härtter S; Grözinger M; Weigmann H; Röschke J; Hiemke C
    Clin Pharmacol Ther; 2000 Jan; 67(1):1-6. PubMed ID: 10668847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential drug interactions with melatonin.
    Papagiannidou E; Skene DJ; Ioannides C
    Physiol Behav; 2014 May; 131():17-24. PubMed ID: 24732412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin.
    Härtter S; Korhonen T; Lundgren S; Rane A; Tolonen A; Turpeinen M; Laine K
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):300-4. PubMed ID: 17040215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism.
    Hilli J; Korhonen T; Turpeinen M; Hokkanen J; Mattila S; Laine K
    J Clin Pharmacol; 2008 Aug; 48(8):986-94. PubMed ID: 18490497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.
    Skene DJ; Bojkowski CJ; Arendt J
    Br J Clin Pharmacol; 1994 Feb; 37(2):181-6. PubMed ID: 8186063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of three-compartment physiologically based pharmacokinetic modeling to predict hepatic blood levels of fluvoxamine relevant for drug-drug interactions.
    Iga K
    J Pharm Sci; 2015 Apr; 104(4):1478-91. PubMed ID: 25558834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ; Jimenez-Jorge S; Molinero P; Rubio A; Guerrero JM; Osuna C
    J Pineal Res; 2008 Sep; 45(2):204-11. PubMed ID: 18507713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactions.
    Karjalainen MJ; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2006 Dec; 34(12):2091-6. PubMed ID: 16985100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa.
    Ikenouchi-Sugita A; Yoshimura R; Hori H; Ueda N; Nakamura J
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):452. PubMed ID: 17610677
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions.
    Karjalainen MJ; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):157-65. PubMed ID: 18816299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants enhance the antinociceptive effects of carbamazepine in the acetic acid-induced writhing test in mice.
    Aoki M; Tsuji M; Takeda H; Harada Y; Nohara J; Matsumiya T; Chiba H
    Eur J Pharmacol; 2006 Nov; 550(1-3):78-83. PubMed ID: 17027750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status epilepticus following intentional overdose of fluvoxamine: a case report with serum fluvoxamine concentration.
    Wood DM; Rajalingam Y; Greene SL; Morgan PE; Gerrie D; Jones AL; Dargan PI
    Clin Toxicol (Phila); 2007; 45(7):791. PubMed ID: 17952747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression.
    Suzuki Y; Fukui N; Sawamura K; Sugai T; Watanabe J; Ono S; Inoue Y; Ozdemir V; Someya T
    J Clin Psychopharmacol; 2008 Jun; 28(3):325-8. PubMed ID: 18480690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluvoxamine on the level of beta-endorphin in the sera and nervous tissue of rats.
    Djurović D; Milic-Askrabić J; Majkić-Singh N
    Pharmazie; 1998 Feb; 53(2):143-4. PubMed ID: 9540114
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.